Association of Exercise-Based Cardiac Rehabilitation with Progression of Paroxysmal to Sustained Atrial Fibrillation
- PMID: 33498648
- PMCID: PMC7865453
- DOI: 10.3390/jcm10030435
Association of Exercise-Based Cardiac Rehabilitation with Progression of Paroxysmal to Sustained Atrial Fibrillation
Abstract
Progression of atrial fibrillation (AF) is associated with worsened prognosis for cardiovascular events and mortality. Exercise-based-cardiac rehabilitation programmes have shown preliminary promise for primary and secondary prevention of AF. Yet, such interventions are typically reserved for patients with acute coronary syndrome or undergoing revascularization. Using a retrospective cohort design, the present study investigated the association of exercise-based cardiac rehabilitation on the progression of paroxysmal to sustained AF, compared to propensity-matched controls. Patients with a diagnosis of paroxysmal AF were compared between those with and without an electronic medical record of exercise-based cardiac rehabilitation within 6-months of diagnosis. Using cox regression models, we ascertained odds of 2-year incidence for AF progression. This cohort of 9808 patients with paroxysmal AF demonstrated that exercise-based cardiac rehabilitation was associated with 26% lower odds of AF progression (odds ratio 0.74, 95% CI 0.66-0.83) compared to propensity-matched controls. This beneficial effect seemed to vary across patient subgroups. In conclusion, findings revealed that exercise-based cardiac rehabilitation was associated with significantly lower odds of progression from paroxysmal to sustained AF at 2-years follow-up compared to propensity-matched controls.
Keywords: atrial fibrillation; cardiac rehabilitation; disease progression; rehabilitation; secondary prevention.
Conflict of interest statement
Benjamin J. R. Buckley has received funding from Pfizer. Stephanie L. Harrison has received funding from Bristol-Myers Squibb (BMS). Elnara Fazio-Eynullayeva and Paula Underhill are employees of TriNetX LLC. Deirdre A. Lane has received investigator-initiated educational grants from Bristol-Myers Squibb (BMS), has been a speaker for Boehringer Ingeheim, and BMS/Pfizer and has consulted for BMS, Boehringer Ingelheim, and Daiichi-Sankyo. Gregory Y. H. Lip: consultant for Bayer/Janssen, BMS/Pfizer, Medtronic, Boehringer Ingelheim, Novartis, Verseon and Daiichi-Sankyo and speaker for Bayer, BMS/Pfizer, Medtronic, Boehringer Ingelheim, and Daiichi–Sankyo. No fees are directly received personally.
References
-
- Elliott A.D., Linz D., Mishima R., Kadhim K., Gallagher C., Middeldorp M.E., Verdicchio C.V., Hendriks J.M.L., Lau D.H., la Gerche A., et al. Association between physical activity and risk of incident arrhythmias in 402 406 individuals: Evidence from the UK Biobank cohort. Eur. Heart J. 2020;41:1479–1486. doi: 10.1093/eurheartj/ehz897. - DOI - PubMed
-
- Rienstra M., Hobbelt A.H., Alings M., Tijssen J.G.P., Smit M.D., Brügemann J., Geelhoed B., Tieleman R.G., Hillege H.L., Tukkie R., et al. Targeted therapy of underlying conditions improves sinus rhythm maintenance in patients with persistent atrial fibrillation: Results of the RACE 3 trial. Eur. Heart J. 2018;39:2987–2996. doi: 10.1093/eurheartj/ehx739. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
